Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +2.59% |
|
+11.55% | -0.50% |
14/05 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
13/05 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.50% | 3.44Cr | |
+17.11% | 8.3TCr | |
-25.70% | 7.37TCr | |
0.00% | 2.65TCr | |
+2.67% | 1.77TCr | |
-8.71% | 1.75TCr | |
+4.87% | 1.61TCr | |
+79.85% | 1.38TCr | |
+73.90% | 1.28TCr | |
-25.96% | 1.27TCr |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Exagen Inc. announced that it expects to receive financing